RecruitingRecruiting
PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)
NCT07143747 · Western University, Canada
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
This is a single centre, study in university-aged participants diagnosed with mild asthma as indicated by a prescription for a short acting bronchodilator for use as needed.
Each participant will participate in one research study visit which includes pre- and post- bronchodilator (BD) spirometry, plethysmography, oscillometry, 129Xe MRI as well as pre-BD ultra-low dose chest CT, Tc99CImaging, blood CBC, sputum induction, as well as completion of the ACQ and AQLQ questionnaires.
Eligibility criteria
Inclusion Criteria:
Participants eligible for inclusion in this study must meet all of the following criteria:
1. Participant diagnosed with mild (GINA1) asthma by physician
2. Participant understands study procedures and is willing to participate in the study as indicated by the participant's signature
3. Provision of written, informed consent prior to any study specific procedures
4. Males and females 17 to 35 years of age
5. Women of childbearing potential (after menarche) must ensure that they are using an effective form of birth control for at least 2 months prior to each imaging visit. Examples of effective birth control include:
1. True sexual abstinence
2. A vasectomized sexual partner
3. Implanon®
4. Female sterilization by tubal occlusion
5. Effective intrauterine device (IUD)/levonogestrel intrauterine system (IUS)
6. Depo-Provera™ injections
7. Oral contraceptive
8. Evra Patch™
9. Nuvaring™
Exclusion Criteria:
Participants fulfilling any of the following criteria are not eligible for inclusion in this study:
1. Participant has an implanted mechanically, electrically, or magnetically activated device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bioprosthesis, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants) (at the discretion of the MRI Technologist)
2. In the investigator's opinion, subject suffers from any physical, psychological or other condition(s) that might prevent performance of the MRI, CT, or Tc99CImaging, such as severe claustrophobia
3. Participants who are pregnant, breastfeeding or have a positive pregnancy test at initial screening visit
4. Participant is unable to perform spirometry or plethysmography maneuvers
5. Participant is unable to perform MRI and CT breath-hold maneuvers
Study design
Enrollment target: 40 participants
Age groups: child, adult
Timeline
Starts: 2026-03-02
Estimated completion: 2028-12
Last updated: 2026-07-31
Interventions
Other: Hyperpolarized 129Xe MRIOther: Tc-99m Technegas Ventilation Imaging
Primary outcomes
- • Measure 129Xe and Tc99C Imaging ventilation defects qualitatively and quantitatively in participants diagnosed and treated as "mild" asthma. (1 baseline visit for pre- and post-bronchodilator imaging assessments)
Sponsor
Dr. Grace Parraga · other
With: Cyclomedica Australia PTY Limited
Contacts & investigators
ContactGrace E Parraga, PhD · contact · gparraga@robarts.ca · 519-931-5777
ContactAngela P Wilson, RRT · contact · awilson@robarts.ca · 519-931-5777
InvestigatorGrace E Parraga, PhD · principal_investigator, Robarts Research Institute, The University of Western Ontario
All locations (1)
Robarts Research Institute; The University of Western OntarioRecruiting
London, Ontario, Canada